Posted on 1/28/20
Concert Pharmaceuticals Proposes Public Offering of Common Stock
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it intends to offer and sell shares of its common stock in an underwritten registered public . . .
Posted on 1/27/20
NeuroMetrix Reports Q4 and Full Year 2019 Financial Results
WOBURN, Mass., Jan. 27, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, . . .
Posted on 1/27/20
An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences
Last year, Bristol-Myers Squibb (NYSE:BMY) spent $74 billion for Celgene and its mixed bag of commercial and clinical-stage drugs. Analysts are still arguing about whether the . . .
Posted on 1/27/20
EyePoint Pharmaceuticals: Gaining Traction
SummaryEyePoint Pharmaceuticals posted preliminary fourth quarter and full year 2019 revenue guidance on Thursday.Data showed the company has shown considerable progress ramping up sales in its . . .
Posted on 1/27/20
Better Buy: Vertex Pharmaceuticals vs. Galapagos
Vertex Pharmaceuticals (NASDAQ:VRTX) turned in a very good performance in 2019, with its shares jumping 32% -- slightly outpacing the S&P 500 index's 30.4% return. But . . .
Posted on 1/27/20
Is Biogen Stock a Buy?
Investors who bought shares of Biogen (NASDAQ:BIIB) in 2010 or earlier and held onto them have plenty of reason to smile; Biogen has gained more than . . .
Posted on 1/26/20
Eleanor Health Opens Fourth Clinic In North Carolina
Eleanor Health, the first addiction and mental health services provider designed to deliver a whole-person, long-term patient recovery outcomes and modeled on value-based care delivery and . . .
Posted on 1/24/20
Bristol-Myers Squibb: The Merger Is Complete, Time To Shine
SummaryBristol-Myers Squibb has finally completed the acquisition of Celgene, now is the time to shine.The company performed incredibly well in 2019 - better than it originally . . .
Posted on 1/24/20
Syros Pharmaceuticals Update: Still A Buy
SummarySyros Pharma has 2 clinical stage drugs under development.New collaboration with Global Blood is a plus.Mark Alles joining the board is intriguing.Syros Pharmaceuticals (SYRS) is a . . .
Posted on 1/24/20
Genprex Prices $8M Common Stock Offering Priced At-The-Market
AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new and potentially life-saving approach to treating some of . . .
Posted on 1/23/20
ImmunoGen Prices Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced the pricing of . . .
Posted on 1/23/20
ImmunoGen Announces Proposed Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that it intends . . .
Posted on 1/23/20
Tetraphase Pharmaceuticals Announces $17.5 Million of Financings
WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVATM (eravacycline for injection) to treat serious and life-threatening infections, . . .
Posted on 1/22/20
athenahealth Honored in Built In Austin’s and Boston’s Respected Best Places to Work Lists in 2020
WATERTOWN, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services for ambulatory and enterprise customers nationwide, today announced it was . . .
Posted on 1/22/20
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement
LEIDEN, the Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ncardia and BlueRock Therapeutics today announced an agreement covering process development technologies for the manufacture of induced pluripotent stem cell . . .
Posted on 1/22/20
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that it has commenced an . . .
Posted on 1/21/20
Steward Health Care System to Deploy “One Platform” with MEDITECH Across 35 Hospitals
WESTWOOD, Mass.--(BUSINESS WIRE)--MEDITECH is proud to announce it will extend its 20-year partnership with Steward Health Care System, which recently signed to implement the company’s innovative . . .
Posted on 1/21/20
Access Sports Medicine & Orthopaedics Appoints Michael LeGeyt, MD Board Certified Orthopaedic Surgeon
Access Sports Medicine & Orthopaedics is pleased to welcome Michael T. LeGeyt, MD to the orthopaedic team at our Exeter, Dover and Portsmouth locations.Dr. LeGeyt specializes . . .
Posted on 1/21/20
XRHealth and VA St. Louis Healthcare System Partner
XRHealth, formerly known as VRHealth, the leader in extended reality and therapeutic applications, today announced that they partnered with the VA St. Louis Healthcare System to . . .
Posted on 1/17/20
Better Buy: General Electric vs. Boeing
These two companies have a lot in common. They're partners in the aviation industry, both have stumbled in recent years due to operational issues, and both . . .
Posted on 1/17/20
Why Biogen Stock Slumped Last Year
What happenedBiotech heavyweight Biogen (NASDAQ:BIIB) failed to follow the broader industry higher last year. Despite biotech stocks at large posting market-beating gains in 2019, Biogen's shares . . .
Posted on 1/17/20
Planet Fitness Ranked #7 In Entrepreneur Magazine's Franchise 500
Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing global franchisors and operators of fitness centers with more members than any other fitness brand, . . .
Posted on 1/16/20
Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment
WILMINGTON, Mass. & EDINBURGH, Scotland--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusive partnership with Fios Genomics, a . . .
Posted on 1/16/20
One Medical Teams Up with Partners HealthCare
BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--One Medical, the modernized membership-based primary care platform, and Partners HealthCare, an integrated non-profit health system founded by Brigham and Women’s Hospital . . .
Posted on 1/15/20
ConsumerMedical Begins 2020 with Addition of 43 New Clients
ConsumerMedical, a clinical advocacy, decision support and expert second opinion company, announced this week at a company-wide meeting the addition of 43 new clients and the . . .

